v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net income $ 21,139 $ 23,496
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 2,319 2,607
Amortization of debt issuance costs 1,164 85
Amortization of deferred commissions costs 14,582 10,989
Noncash stock-based compensation 35,290 30,180
Noncash operating lease expense 1,916 1,636
Noncash change in fair value of contingent consideration 0 (545)
Noncash adjustment on headquarters sale leaseback 0 495
Deferred income taxes 2,962 3,908
Other (182) (61)
Changes in operating assets and liabilities:    
Trade accounts receivable, net 58,714 3,748
Other current assets and Other assets (23,190) 2,378
Deferred commissions cost (21,299) (15,072)
Accounts payable (506) (320)
Accrued liabilities (26,281) (47,260)
Operating lease liabilities (1,889) (1,908)
Deferred revenue (12,308) 17,440
Other liabilities (761) (115)
Net cash provided by operating activities 51,670 31,681
Cash flows from investing activities    
Purchase of property and equipment (569) (1,879)
Purchase of investments (7,895) (6,144)
Proceeds from sale of headquarters, net 0 34,849
Net cash provided by (used in) investing activities (8,464) 26,826
Cash flows from financing activities    
Repurchase of common stock (10,131) (15,050)
Payment of debt issuance costs 0 (1,846)
Other (75) (12)
Net cash used in financing activities (10,206) (16,908)
Effects of exchange rate — changes in cash (3,150) 19,532
Net increase in cash and cash equivalents 29,850 61,131
Cash and cash equivalents at beginning of period 899,987 302,103
Cash and cash equivalents at end of period 929,837 363,234
Supplemental disclosures of noncash activities    
Operating lease liabilities arising from obtaining right-of-use assets $ 932 $ 20,252